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There is much interest in understanding the mechanisms responsible for interactions among stress, aging, memory and Alzheimer’s
disease. Glucocorticoid secretion associated with early life stress may contribute to the variability of the aging process and to the
development of neuro- and psychopathologies. Maternal separation (MS), a model of early life stress in which rats experience 3 h of daily
separation from the dam during the first 3 weeks of life, was used to study the interactions between stress and aging. Young (3 months)
MS rats showed an altered hypothalamic–pituitary–adrenal (HPA) axis reactivity, depressive-like behavior in the Porsolt swimming test
and cognitive impairments in the Morris water maze and new object recognition test that persisted in aged (18 months) rats. Levels of
insulin receptor, phosphorylated insulin receptor and markers of downstream signaling pathways (pAkt, pGSK3b, pTau, and pERK1
levels) were significantly decreased in aged rats. There was a significant decrease in pERK2 and in the plasticity marker ARC in MS aged
rats compared with single MS or aged rats. It is interesting to note that there was a significant increase in the C99 : C83 ratio, Ab levels,
and BACE1 levels the hippocampus of MS aged rats, suggesting that in aged rats subjected to early life stress, there was an increase in the
amyloidogenic processing of amyloid precursor protein (APP). These results are integrated in a tentative mechanism through which aging
interplay with stress to influence cognition as the basis of Alzheimer disease (AD). The present results may provide the proof-of-concept
for the use of glucocorticoid-/insulin-related drugs in the treatment of AD.
Neuropsychopharmacology (2010) 35, 1664–1673; doi:10.1038/npp.2010.13; published online 24 February 2010
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INTRODUCTION
Stress is believed to contribute to the variability of the aging
process and to the development of age-related neuro- and
psychopathologies (Heim and Nemeroff 1999; McEwen,
2002; Miller and O’Callaghan, 2005). Clinical data suggest
that a stressful lifestyle can be a risk factor for Alzheimer’s
disease (AD) (Wilson et al, 2005) and stress-related psy-
chiatric disorders (ie, major depression) have been identi-
fied as a risk for developing AD (Ownby et al, 2006). There
is much interest, therefore, in understanding the mecha-
nisms responsible for interactions among stress, aging and
memory.
The effects of stress are thought to be mediated by the
activation of the hypothalamic–pituitary–adrenal (HPA)
axis, culminating in increased levels of glucocorticoids
(Berton and Nestler, 2006). Aged rats and elderly humans
show progressive loss of control of the HPA axis, resulting
in hypersecretion of glucocorticoids (Sapolsky et al, 1983;
Born et al, 1995). Abnormal glucocorticoid secretion is
thought to be involved in many aging-related diseases,
including depression (Kendler et al, 1999), memory
impairments (Sapolsky et al, 1986; Lupien et al, 1998; Aisa
et al, 2007) and AD (Hartmann et al, 1997; Elgh et al, 2006).
In experimental models of AD, stress or glucocorticoids
exacerbated AD-like neuropathology (Green et al, 2006;
Jeong et al, 2006). Glucocorticoids not only have been
suggested to contribute to age-related loss of neurons in the
hippocampus of rats (Sapolsky, 1985), but also have been
shown to potentiate hippocampal damage induced by
various noxious insults (Sapolsky and Pulsinelli, 1985)
including the amyloid b (Ab) peptide, the main component
of senile plaques in AD (Catania et al, 2009). Thus, a
recently developed view suggests that hypercortisolemia,
leading to hippocampal atrophy and further HPA axis
disinhibition (ie, ‘the glucocorticoid cascade hypothesis’),
would initiate a chain of events, ultimately culminating
in the development of lesions typical of AD (Dhikav and
Anand, 2007). The mechanisms underlying the effects
of altered glucocorticoid levels remain largely unknown.
However, among them, it is worth mentioning the inter-
relation between glucocorticoids and insulin. Glucocorti-
coid excess results in insulin resistance by blunting insulin’s
Received 23 September 2009; revised 22 January 2010; accepted 25
January 2010
*Correspondence: Dr MJ Ramı´rez, Department of Pharmacology,
University of Navarra, Center for Applied Medical Research,
C/ Irunlarrea, 1, Pamplona, 31008, Spain, Tel: + 34 948 425 600,
Fax: + 34 948 425 649, E-mail: mariaja@unav.es
Neuropsychopharmacology (2010) 35, 1664–1673
& 2010 Nature Publishing Group All rights reserved 0893-133X/10 $32.00
www.neuropsychopharmacology.org
action to suppress hepatic glucose production and stimulate
peripheral glucose utilization (Amatruda et al, 1985). In
addition to their effects on insulin sensitivity, glucocorti-
coids inhibit insulin secretion from pancreatic b-cells
(Delaunay et al, 1997; Lambillotte et al, 1997). Glucocorti-
coids are elevated in rodents with experimental diabetes
(Magarin˜os and McEwen, 2000) and it has been suggested
that cognitive impairment in diabetes may result from
glucocorticoid-mediated deficits in neurogenesis and
synaptic plasticity (Stranahan et al, 2008).
Maternal separation (MS) is an animal paradigm designed
to mimic repeated exposure to stress during early life,
resulting in animals with behavioral and neuroendocrine
signs of elevated stress reactivity as adults (Lehmann and
Feldon, 2000; Heim and Nemeroff, 2001; Aisa et al, 2007).
The peak period of neurogenesis overlaps the stress
hyporesponsive period (postnatal days, PND 4–14) in
neonatal rats (Sapolsky and Meaney, 1986). Therefore, early
stress, such as MS, could be interfering with the normal
maturation of the hippocampal structure, which might
ultimately lead to an increased vulnerability for psychiatric
diseases. After the early developmental period, it is at
present unknown how stress will have an effect on the aging
process because of a lack of studies.
In this work we have studied the effects of an early life
stress in aged rats. The main results found are that the
interaction between stress and aging induced: (1) altered
HPA axis reactivity, depressive-like behavior, cognitive
impairments, intracellular insulin pathways alterations and
plastic changes; and (2) promoted amyloid precursor
protein (APP) processing towards the amyloidogenic path-
way. These results provide a tentative mechanism through
which aging interplay with stress to influence cognition,
with a bias towards consideration of insulin-mediated
mechanisms and neuroplastic events in the hippocampus,
as the basis of AD.
MATERIALS AND METHODS
Animals
All the experiments were carried out in strict compliance
with the recommendations of the EU (DOCE L 358/1
18/2/1986) for the care and use of laboratory animals.
Timed-pregnant Wistar rats were provided on gestation
day 16 from Charles River Laboratories (Portage, MI, USA),
individually housed in a temperature (21±11C) and
humidity (55±5%) controlled room on a 12-h light–dark
cycle (lights on at 0800 h) with food and water freely
available. Every effort was made to minimize the number of
animals used and their suffering.
MS Procedure
On PND 2 (Aisa et al, 2007; Ladd et al, 2004), all pups were
sexed and randomly assigned to the control group (pups
manipulated to change the bedding in their cages once
weekly), or the separation group (MS, pups separated daily
from their dam as a litter for 3 h from PND 2–21 inclusive).
Rats were weaned on PND 23 and only males were chosen
for the present work. Subsequent experiments were carried
out in young (60–75 days) and aged rats (18 months). Rats
were not allowed to grow older as mortality increased
significantly in the aged MS group. Animals from different
litters were evenly spread over the different experimental
groups. Animals were monthly weighted.
Behavioral Test
Behavioral experiments were conducted between 0900 h and
1300 h. Observers were blind to the rearing condition.
A different animal cohort was used for carrying out each
of the different test.
Locomotor Activity
Locomotor activity was measured for 30 min in an open
field (65 65 cm2, 45 cm height) made of black wood,
using a video-tracking system (Ethovision 3.0, Noldus
Information Technology B.V., The Netherlands), in a softly
illuminated room. Total path length (cm) was analyzed.
Forced Swimming Test
The test was carried out as described (Porsolt et al, 1977).
Briefly, two swimming sessions were conducted: an initial
15-min pre-test followed 24 h later by a 5-min test. Rats were
placed individually in a vertical Plexiglas cylinder (height:
60 cm, diameter: 30 cm) filled with 45 cm of 23±11C water.
Immobility was considered as rats floating passively, making
only small movements to keep its nose above the surface.
Object Recognition Test (NORT)
As previously described (Aisa et al, 2007), the open field
consisted of a square open field (65 cm 65 cm 45 cm)
made of black wood. On the previous day to the experiment,
animals were familiarized with the square for 30 min.
During the first trial, two identical objects were placed
within the chamber, and the rat was allowed to freely
explore during 5 min. Exploration was considered when the
head of the rat was oriented toward the object with its nose
within 2 cm of the object. An hour later a second trial took
place, in which one object was replaced by another, and
exploration was scored for 5 min. Results were expressed as
percentage of time spent with the new object with respect to
the total exploration time (discrimination index).
Morris Water Maze
This memory task was carried out as previously described
(Diez-Ariza et al, 2003). The maze consisted of a black
circular tank (140 cm diameter 55 cm high) and filled with
water (20–221C). A black invisible platform, 10 cm diameter,
was positioned 1 cm below the water surface. A video
camera was set above the center of the pool and connected
to a video traction system (EthoVision; Noldus Information
Technology B.V.). The pool was surrounded by white
curtains marked with black geometric paintings, so as to
enable the animals to learn the platform location. On the
first day, each rat becomes habituated to the training
environment for 60 s. In the acquisition phase (days 2–3),
rats performed 6 training trials per day (120 s each) with the
escape platform in a fixed position. Time spent to reach the
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platform (latency), the swim path length (distance swam),
and the swim speed (cm/s) were recorded. The results on
time to reach the platform are not shown as, in all cases,
parallel with distances swam. On day 4, (retention phase) a
single transfer test was carried out, in which the platform
was removed from the tank. The animal was allowed to
swim for 60 s in search of the platform. The distance swam
in the quadrant where the platform was previously located
was measured.
Biochemical Measurements
Tissue and blood collection. Fasting rats were killed by
decapitation between 0800–1000 h. Brains were removed
and dissected on ice to obtain the hippocampus or frozen
immediately and stored at 80 1C until sectioning. Trunk
blood was collected into EDTA tubes, centrifuged at 1250 g
(15 min, 41C), and plasma was frozen.
Plasma corticosterone, insulin and IGF1 determinations.
Plasma corticosterone (50 ml) was determined using a
commercially available solid-phase 125I radioimmunoassay
kit (Coat-a-Count, Siemens, USA). Insulin was measured
in 10 ml plasma samples using the Sensitive Rat Insulin
Enzyme Immunoassay Kit (EZRMI-13K, Millipore, Billerica,
MA, USA). IGF1 levels were determined using a commer-
cially available solid-phase 125I radioimmunoassay kit (DSL-
2900, Diagnostic System Laboratories, TX, USA).
Western blotting. Assays were carried out as described in
Table 1. Immunopositive bands were visualized using an
enhanced chemiluminescense western blotting-detection
reagent (ECL; Amersham, Buckinghamsire, England). The
optical density (O.D.) of reactive bands visible on X-ray film
was determined densitometrically. b-actin or a-tubulin was
used as internal control. Results were expressed as
percentage of O.D. values of control young rats.
Ab levels. Ab1–42 levels were determined using a commer-
cially available high-sensitive ELISA kit (Wako Pure
Chemical Industries, Tokyo, Japan) following manufacturer
instructions.
In situ hybridization for BDNF and activity-regulated
cytoskeletal-associated protein (ARC) mRNA. Coronal
brain sections containing the hippocampus (15 mm thick)
were cut at the level of 3.3 mm (relative to the bregma)
according to the atlas of Paxinos and Watson (1982). The
oligonucleotides used were: 50-AGTTCCAGTGCCTTTTGTC
TATGCCCCTGCAGCCTTTGGTGTAAC-30 for BDNF and
50-CTTGGTTGCCCATCCTCACCTGGCACCCAAGACTGGT
ATTGCTGA-30 for ARC, both from Sigma Genosis,
UK. Probes were 30-tail labeled with aS[35S]dATP, specific
activity 41000 Ci/mmol (GE Healthcare Biosciences,
Europe). Negative controls including sense oligonucleotides
showed minimal background signals. Sections were exposed
to Biomax MR film (Kodak) for 3 days (BDNF) or 3 weeks
(ARC). The relative abundance mRNA in each region was
determined by densitometric quantification of autoradio-
grams using an image analysis system (Scion Image, Scion
Corporation, USA) correcting for non-specific signals. O.D.
values were calibrated to 35S tissue equivalents using 14C
Table 1 Conditions used in western blotting experiments
Protein Homogenization buffer SDS–polyacrylamide gel Primary antibody (dilution)
IDE Buffer 1 13% Anti-IDE (1:1000)a
pAkt Buffer 1 13% Anti-pAkt Ser473 (1 : 1000)b
Total Akt Buffer 1 13% Anti-Akt (1 : 1000)b
pGSK3b Buffer 1 13% Anti-pGSK3b Ser 9 (1 : 1000)b
Total GSK3b Buffer 1 13% Anti pGSK3b (1 : 1000)b
pERK 1/2 Buffer 1 13% Anti-p44/42 Thr202/Tyr204 (1 : 2000)b
Total ERK 1/2 Buffer 1 13% Anti-ERK 1/2 (1 : 2000)b
pTau Buffer 1 13% Anti-pTau Ser202/Thr205 AT8 (1 : 1000)c
Total Tau Buffer 1 13% Anti-Tau T46 (1 : 3000)d
GR Buffer 1 8% Anti-GR (1 : 2000)e
IR Buffer 2 8% Anti-IR (1 : 500)b
pIR Buffer 2 8% Anti-pIR (1 : 500)a
APP C-terminal Buffer 2 4–12% gradient gel Anti-APP C-terminal (676–695) (1 : 2000)d
BACE1 Buffer 2 4–12% gradient gel Anti BACE1 (1 : 1000)a
Abbreviations: APP C-terminal, APP carboxy-terminal fragments (C83 and C99); GR, glucocorticoid receptor; IDE, insulin degrading enzyme; IR, insulin receptor.
Buffer 1: 50 mmol/l Tris–HCl, pH 8; 150 mmol/l NaCl, 2 mmol/l EDTA, 2 mmol/l EGTA, 0.5 mmol/l phenylmethanesulfonyl fluoride, 1 mmol/l sodium vanadate,
10 mg/ml leupeptin, and 1% Nonidet P-40, 1 : 100 of phosphatases inhibitors cocktail set II (Calbiochem, Darmstadt, Germany); buffer 2: SDS 2%, Tris–HCl
(10 mM, pH 7.4), protease inhibitors (Complete Protease Inhibitor Cocktail, Roche), and phosphatase inhibitors (0.1 mM Na3VO4, 1 mM NaF).
Source of antibodies:
aAbcam, Cambridge, MA, USA.
bCell Signaling Technology, Beverly, MA, USA.
cPierce, Rockford, IL, USA.
dSigma-Aldrich, St. Louis, MO, USA.
eSanta Cruz Biotechnology, CA.
Insulin and the interaction between age and stress
M Solas et al
1666
Neuropsychopharmacology
microascales (Amersham, UK) and the appropriate conver-
sion factor. Densitometric values from three sections of
each animal were averaged and expressed as nCi/g tissue.
Data analysis. Data were analyzed by SPSS for Windows,
release 15.0 and normality was checked by Shapiro–Wilks’s
test (po0.05). In the acquisition phase of the Morris water
maze, over-all treatment effects were examined by two-way
repeated measures ANOVA (rearing trial). Differences
between trials within groups were analyzed using a factorial
ANOVA with replicates. Data in the retention phase were
analyzed with one-way ANOVA. Neurochemical data was
analyzed by two-way analysis (rearing age) of variance
ANOVA. Post hoc comparisons were conducted, if appro-
priate, using Tukey’s protected least significance test. Data
are presented as mean±SEM. The level of significance for
all analyses testing was set at po0.05.
RESULTS
Overall Effects of Stress and Age on Weight Gain,
Locomotor Activity, and Depression-Like Behavior
As shown in Table 2, there was a main effect of age in weight
gain (two-way ANOVA, F1,60¼ 180.673, po0.001; n¼ 10–22)
and locomotor activity (F1,82¼ 330.239, po0.001; n¼ 10–17)
(Table 2).
In the forced swimming test, there was an increased
immobility time, indicative of depressive-like behavior, in
both young and aged MS rats (two-way ANOVA, main effect
of rearing, F1,82¼ 17.217, po0.001; n¼ 10–17) (Table 2).
Effects of Age and MS on Cognition
In the acquisition phase of Morris water maze, distance swam to
reach the platform improved significantly over trials in all
groups (factorial ANOVA with replicates) and no significant
effect of rearing or age was found. However, in the retention
phase, both rearing (F1,55¼ 7.199, po0.05; n¼ 8–21) and age
(F1,55¼ 14.220, po0.001; n¼ 8–21) produced a statistically
significant decrease in distance swam in the quadrant were the
platform used to be located, indicative of a memory impairment
(Figure 1a). Swim speed was not affected by rearing or age.
A two-way ANOVA indicated a main effect of rearing in
the NORT, and MS rats showed a learning impairment
(F1,58¼ 8.964, po0.01; n¼ 12–18) as the discrimination
index was significantly lower (Figure 1b).
Age and MS Interact to Affect HPA Axis
There was a significant rearing age interaction in plasma
corticosterone levels (two-way ANOVA, F1,50¼ 4.689, po0.05;
n¼ 8–19). Further analysis showed a significant increase in
corticosterone levels in young MS rats (Student’s t-test; po0.05)
and almost significant effect in aged MS rats (Student’s t-test;
p¼ 0.06) compared with young controls (Table 2).
Hippocampal glucocorticoid receptor density mediates the
glucocorticoid negative feedback to modulate HPA axis
activity. Statistical analysis indicates a significant inter-
action between rearing and age (F1,34¼ 11.671, po0.01;
n¼ 8–10). Post-hoc analysis showed that, compared with
young controls, there was a significant decrease in gluco-
corticoid receptor levels in young MS, aged controls and
aged MS (Student’s t-test; po0.001, in all cases). Gluco-
corticoid receptors were also decreased when comparing
young and aged MS rats (Student’s t-test; po0.05) (Table 2).
Age and MS Interact to Affect Insulin Levels, IDE
and Intracellular Insulin Pathways
There was an interaction (F1,39¼ 3.776, po0.05; n¼ 10)
between rearing and age in fasting plasma insulin levels.
Table 2 Effects of age and maternal separation (MS) on weight, locomotor activity, depressive-like behaviour, markers of HPA axis activity,
and insulin pathways
Young (3 months) Aged (18 months)
Control MS Control MS
Weight (g) 315.40±5.72 311.80±10.30 721.78±33.50a 696.86±25.44a
Locomotor activity (cm) 6910.08±300.92 7704.13±378.52 2333.15±172.17a 2536.27±553.46a
Porsolt, immobility time (s) 72.50±10.67 111.00±5.91b 55.92±6.49 95.76±9.56b
Corticosterone (ng/ml) 392.70±51.08 579.41±25.16c 566.65±58.93 525.49±39.86
GR (% O.D.) 100.00±2.94 54.78±9.90d 24.15±5.01d 27.16±8.48d,e
Insulin (ng/ml) 3.74±0.45 2.27±0.40c 1.98±0.26c 1.81±0.26d
IGF1 (ng/ml) 1321.70±50.50 1274.90±35.87 1104.11±47.33a 967.82±52.24a
IDE (% O.D.) 100.00±10.68 64.96±9.43c 51.76±6.09d 71.94±10.51
Total IR (% O.D.) 100.00±4.48 92.49±6.71 54.98±6.73a 51.52±8.78a
pIR (% O.D.) 100.00±12.43 86.09±10.97 39.82±1.68a 17.55±0.79a
Abbreviations: HPA, hypothalamic–pituitary–adrenal; IDE, insulin degrading enzyme; IGF1, insulin-like growth factor 1; IR, insulin receptor; O.D., optical density.
N¼ 10 (control and MS young rats), 18 (control aged rats), and 22 (MS aged rats).
apo0.001 main effect of age, two-way ANOVA (rearing age).
bpo0.001 main effect of rearing, two-way ANOVA (rearing age).
cTwo-way ANOVA, significant interaction (rearing age), po0.05 vs control young (3 months) rats.
dTwo-way ANOVA, significant interaction (rearing age) po0.001 vs control young (3 months) rats.
epo0.05 vs MS young (3 months) rats.
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Further analysis showed that there was a significant
decrease in insulin levels in MS young, aged and MS aged
rats (Student’s t-test; po0.05 or po0.01). Levels of insulin-
like growth factor 1 (IGF1) were only affected by age
(F1,39¼ 22.346, po0.001; n¼ 10) (Table 2).
There was a significant interaction (F1,37¼ 8.127, po0.01;
n¼ 10–11) between rearing and age in hippocampal IDE
levels. Further analysis revealed that both the MS procedure
(control vs MS rats, Student’s t-test; po0.05) or age (control
vs aged rats, Student’s t-test; po0.001) produced significant
decreases in IDE levels (Table 2).
There was a main effect of age in levels of insulin
receptors (IRs) (F1,35¼ 23.420, po0.001; n¼ 8–10) and IR
phosphorylation (F1,17¼ 103.992, po0.001; n¼ 4–5)
(Table 2). When studying the insulin pathways, it was
found that there was a main effect of age in levels of
phosphorylated Akt (pAkt) (Ser473) normalized to total Akt
(F1,41¼ 9.606, po0.01; n¼ 8–12) (Figure 2a), pGSK3b (Ser9)
normalized to total GSK3b (F1,32¼ 33.318, po0.001; n¼
6–10) (Figure 2b), pTau (Ser202/Thr205) normalized to
total Tau (F1,35¼ 25.622, po0.001; n¼ 8–10) (Figure 2c)
and pERK1 (Thr202/Tyr204) levels normalized to total
ERK1 (F1,33¼ 20.429, po0.001; n¼ 6–10) (Figure 2d). Con-
sistent with a post-transcriptional regulation of these
enzymes, total Akt, GSK3b, Tau, and ERK1 protein levels,
normalized using actin, remained unaltered. It is interesting
to note that there was an interaction (rearing age) (F1,35¼
6.054, po0.05, n¼ 8–10) in pERK2 (Thr202/Tyr204) levels
normalized to total ERK2. Further analysis showed a
significant decrease in pERK2 in aged MS compared with
young MS or aged rats (Student’s t-test; po0.05 in both
cases) (Figure 2d). Total ERK2 levels normalized using actin
did not show significant changes.
Neonatal Stress Favors the Amyloidogenic Processing
of APP in Aged Rats
As depicted in Figure 3a, APP protein levels were not altered
by rearing condition or age (two-way ANOVA, F1,31¼ 2.030,
p¼ 0.165; n¼ 8). When analyzing the amyloidogenic
route, significant increases in the C99 : C83 ratio were found
associated to rearing (F1,26¼ 4.164, po0.05; n¼ 7–8) or age
(F1,26¼ 5.158, po0.05; n¼ 7–8) (Figure 3a). Ab levels were
also significantly increased by age (F1,22¼ 11.116, po0.01;
n¼ 6) and rearing (F1,22¼ 5.723, po0.05; n¼ 6) (Figure 3b).
Regarding BACE1 levels, there was a main effect of rearing
(F1,22¼ 7.390, po0.05; n¼ 6) and age (F1,22¼ 10.380,
po0.01; n¼ 6) (Figure 3c).
Effect of Age and MS on Synaptic Plasticity
Significant decreases in BDNF mRNA density were found
in the dentate gyrus (DG) (F1,15¼ 14.086, po0.01; n¼ 4–5)
and CA3 regions (F1,15¼ 23.079, po0.01; n¼ 4–5) of the
hippocampus of MS rats compared with control rats. In
the CA1 region there was an interaction rearing age
(F1,14¼ 7.141, po0.05). Post-hoc analysis showed that MS
produced a significant decrease of BDNF expression in
young rats (Student’s t-test; po0.01; n¼ 4) and almost
significant effect in aged rats (Student’s t-test; p¼ 0.08;
n¼ 4) (Figure 4a).
Regarding ARC mRNA levels, there was a main affect
of age and rearing in the DG (F1,15¼ 121.767, po0.001;
n¼ 4–5; and F1,15¼ 386.446, po0.001; n¼ 4–5, respectively)
and CA3 region of the hippocampus (F1,15¼ 89.481,
po0.001; n¼ 4–5; and F1,15¼ 212.861, po0.001; n¼ 4–5,
respectively). In the CA1 region, there was an interaction
(rearing age) (F1,15¼ 10.448, po0.01; n¼ 4–5). Further
analysis showed significant decreases in ARC mRNA
expression in MS young (Student’s t-test, po0.001; n¼ 4),
aged (Student’s t-test, po0.001; n¼ 4–5), and MS-aged rats
(Student’s t-test; po0.001; n¼ 4–5) compared to control
young rats, and further decreases in MS aged rats compared
with MS young rats (Student’s t-test; po0.001; n¼ 4).
DISCUSSION
The MS model in rat is considered nowadays as a robust
model of enhanced stress responsiveness (Ladd et al, 2000;
Lehmann and Feldon, 2000; Oitzl et al, 2000; Aisa et al,
2007). Even though several studies have focus in the
characterization of the MS model in adult animals, little
work has been done on how neonatal stress would impact
the aging process. In our hands, not only the behavioral
(depression-like) effects of MS persisted until senescence
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Figure 1 Effects of age and maternal separation (MS) on cognition. (a) Retention phase of the Morris water maze, data are presented as distance swam in
the quadrant where platform used to be located. There was a main effect of rearing (F1,55¼ 7.199, po0.05) and age (F1,55¼ 14.220, po0.001). (b) New
object recognition test, data presented as discrimination index: time exploring the new object/total exploration time 100. There was a main effect of
rearing (F1,58¼ 8.964, po0.01). 3 m: 3 months, young rats; and 18 m: 18 months, aged rats *po0.001 main effect of rearing, wpo0.05 or better, main effect
of age.
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but also our findings suggest that neonatal stress may have
accelerated cognitive decline, at least in the Morris water
maze, a hippocampal-dependant task. The results found
on the NORT, together with the fact that the hippocampus
is only minimally involved in memory for objects (Brown
and Aggleton, 2001), would support the notion that the
interaction age-stress in memory deficits mainly has its
anatomical substrate on the hippocampus. It is worth
mentioning that even though aged rats seem to have a
decreased activity in the open field test, other measure-
ments of locomotor activity, such as swim speed in the
Morris water maze or total exploration time in the first
exposure to objects in the NORT, did not differ among
groups.
Age and MS Interact to Affect Insulin Pathways
In accordance to our data, it has been described that
alterations in behavior and cognition associated with MS
stress are related to increased levels of glucocorticoids
(Aisa et al, 2007; Wigger and Neumann, 1999). Aging ‘per se’
is also accompanied by a progressive increase in basal
corticosterone levels in rats (Sapolsky et al, 1983; Sapolsky
et al, 1986; Hauger et al, 1994). As described in the Intro-
duction section, the effect of glucocortiocoids in vivo
appears to include a decrease in circulating insulin levels.
Even though the reduced peripheral levels of insulin found
in this study do not necessarily imply equally reduced
insulin levels in the brain (ie, the low levels of IDE in the
hippocampus induced by either stress or ageing could lead
to locally slower insulin degradation), the reduced IR
expression and phosphorylation status suggest that effects
dependent on intracellular insulin pathways activity could
be inhibited in MS aged rats. In addition, it could be
excluded that IGF1, known to be closely related to insulin
and share similar cellular signaling events (Dupont and
LeRoith, 2001) could compensate for insulin decreased
levels.
The insulin signal transduction cascade of the PI3K/Akt/
GSK3b pathway promotes neuronal survival by directly
inactivating the proapoptotic machinery. It is interesting to
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the enzyme, 60 kDa) normalized to total Akt, main effect of age (F1,41¼ 9.606, po0.01; n¼ 8–12); (b) phosphorylated (inactive) GSK3b levels (46 kDa)
normalized to total GSK3b, main effect of age (F1,32¼ 33.318, po0.001; n¼ 6–10); (c) Phosphorylated Tau levels (40–50 kDa) normalized to total Tau,
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po0.05). Figure shows percentage of optical density (O.D.) values of control young rats and representative picture of the blotting. No differences were
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age. wpo0.05 or better vs control young rats, #po0.05 vs MS young rats.
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note that it is this same route that is required for the
induction of long-term potentiation and depression, basic
processes underlying learning and memory (Van der Heide
et al, 2006). In this regard, clinical and epidemiological
studies have found that diabetes and hyperinsulinemia may
be suspected factors to increase the risk of developing AD
(Steen et al, 2005), and it seems that a dysfunction of the IR
facilitates tau hyperphosphorylation (Schubert et al, 2004),
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which forms neurofibrillary tangles, through its regulation
of GSK3b. However, even though according to the
reduced input to the IR in aged rats we found a decreased
phosphorylation of GSK3b, leading to increased activation
of the enzyme and subsequent increased phosphorylation of
tau, no additive effects of stress were seen.
Insulin binding to IR also activates another signal
transduction cascade identified as the MAPK/ERK pathway.
ERK1/2 has essential roles in neuronal survival (Xia et al,
1995) and synaptic plasticity related to learning and
memory formation (Davis and Laroche, 2006). Further-
more, early work demonstrated an absolute requirement for
ERK activity in induction of LTP (English and Sweatt, 1996)
and memory consolidation (Eckel-Mahan et al, 2008).
Supported by a recent study showing that the micro-
deletions of the ERK2 gene leads to cognitive deficits
(Shaikh et al, 2007), our findings suggest that the ERK2
pathway could be involved in the cognitive deficits observed
in aged MS rats, therefore implicating this insulin signaling
in the stress-associated memory deficits.
Age and MS Interact to Favor an Increase in Levels
of Ab
The principal constituent of amyloid plaques observed
in AD, is the amyloidb-protein (Ab), which is generated
from APP. APP can be cleaved by b-secretase (BACE1) and
a-secretase to produce C99 and C83. These C-terminal
fragments can then be cleaved by g-secretase to produce Ab
and p3, respectively. It has been shown that chronic stress
or elevated glucocorticoid levels potentiate Ab deposition
and induces cognitive deficits in transgenic mouse models
of AD (Green et al, 2006; Jeong et al, 2006). Glucocorticoids
are also able to potentiate hippocampal damage induced
by various noxious insults, including the toxic actions of Ab
(Catania et al, 2009). It has been described that treatment
with soluble human Ab not only disrupted the activation
of ERK and Akt, but also that Ab was able to bind to IR,
interfering with insulin-induced autophosphorylation
(Townsend et al, 2007) or inducing the loss of insulin
receptor at the neuronal surface (Zhao et al, 2008; De Felice
et al, 2009). C99 has intrinsic neurotoxic properties
(Yankner et al, 1989), causes synaptic degeneration
(Oster-Granite et al, 1996) and impairs long-term potentia-
tion (Nalbantoglu et al, 1997) and cognition (Berger-
Sweeney et al, 1999), all these effects most probably are
due to an enhanced Ab generation. In our hands, aging
and stress interacts to favor the amyloidogenic route of
APP processing, and increased Ab formation, probably by
upregulating BACE1 levels. A glucocorticoid response
element in the promoter region of the BACE1 gene has
been described (Sambamurti et al, 2004), making it likely
that glucocorticoids mediates the regulatory actions of
stress on BACE1 expression by directly increasing trans-
cription of this gene.
On the other hand, the expression of IDE, a metallo-
protease that not only catabolises insulin but also has a
crucial part in Ab clearance in the brain (Kurochkin and
Goto, 1994; Qiu et al, 1998), which could be modulated
by glucocorticoids (Kulstad et al, 2005). Therefore, in aged
MS rats, increases in Ab due to the increased amyloidogenic
route and decreased metabolism by IDE, would interfere
with IR function in hippocampal neurons, preventing the
activation of specific kinases (ERK2) required for long term
potentiation.
Synaptic Plasticity
The MS procedure, which took place during critical periods
of hippocampal development, can disrupt hippocampal
cytoarchitecture in a stable manner (Huot et al, 2002),
which may also contribute to the learning deficits observed
in adult/aged animals. It is known that different types
of stress, including MS (Roceri et al, 2002; Duman and
Monteggia, 2006; Warner-Schmidt and Duman, 2006), or
increases in Ab levels (Christensen et al, 2008) induce
reduced BDNF expression. As BDNF signaling activates the
ERK1/2 pathway, it could be suggested that the inhibition
of ERK cascade in MS aged rats could be related to both a
lower BDNF levels and reduced insulin pathways activation.
In addition, ARC expression, which is strongly implicated
in synaptic plasticity and consolidation of long-term
memories (Guzowski et al, 2000), may be up-regulated by
BDNF through ERK (Zheng et al, 2009).
CONCLUSION
Altogether, a tentative mechanism through which stress
exert their effects on aging/AD could be suggested based on
the present results (Figure 5). Our findings demonstrate
that a stress history in the neonatal period exacerbates the
Stress Age
↑BA
CE
1
↑Aβ
↑C99 ↓ insulin
↓ERK2
↓ARC
↓BDNF
COGNITIVE DEFICITS
Neuronal vulnerability
to insults
↓ IR
↑GC
Figure 5 Mechanism through which stress and/or glucocorticoids exerts
their effects on aging/Alzheimer’s disease (AD). Glucocorticoids by
inhibiting the insulin pathway, would lead to a decrease in pERK2 levels,
as well as affecting synaptic plasticity. Therefore neuronal ability would be
compromised to survive insults, such as increases in glucocorticoid-induced
C99 or Ab production.
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age-related cognitive decline and therefore, the extent of
neonatal exposure to glucocorticoids may determine the
extent of age-related cognitive dysfunction (Montaron et al,
2006). It could also be suggested that high levels of
glucocorticoids, found in AD (Hartmann et al, 1997;
Csernansky et al, 2006; Elgh et al, 2006), might not be
merely a consequence of the disease process, but it rather
has a central role in the development and progression of the
illness. Interactions between endogenous (age, genetics, C99
or Ab production) and exogenous factors (stress) might be
important determinants of the onset and progress of AD.
The present findings suggest that stress management or
pharmacological interventions on the glucocorticoids/
insulin pathway warrant additional consideration in the
regimen of AD therapies.
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